Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NZ issues pandemic influenza guidelines

This article was originally published in Scrip

Executive Summary

The New Zealand ministry of health has issued guidelines for public health interventions in the case of pandemic influenza. The Guidelines for Public Health Services on Cluster Control for Pandemic Influenza outline actions for public health units for cluster control should a pandemic occur. The guidelines outline the main aims as to control or eliminate the disease; slow transmission of the disease; and obtain epidemiological information to characterise the spread of the infection to inform pandemic management response. The report advises cluster control should begin as soon as a suspected case is identified, with a confirmed cluster to be treated as a major health emergency. Border management operations are also recommended, and national reserve medication will be provided free of charge to people meeting criteria for provision.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC031250

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel